speb/financial-data huggingface dataset:
LEN.B cash_flow (quarterly, 2025-05-31) — End Cash Position: 1479015000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Financing Cash Flow: -175369000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Finished Goods: 11375461000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Free Cash Flow: -1110238000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Gain Loss On Investment Securities: 61466000.00
LEN.B income_statement (quarterly, 2025-05-31) — Gain On Sale Of Security: -29440000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Gains Losses Not Affecting Retained Earnings: 6019000.00
LEN.B income_statement (quarterly, 2025-05-31) — General And Administrative Expense: 155853000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Goodwill: 3632058000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Goodwill And Other Intangible Assets: 3632058000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Gross PPE: 13965000.00
LEN.B income_statement (quarterly, 2025-05-31) — Gross Profit: 804430000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Held To Maturity Securities: 134280000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Inventory: 14516800000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Invested Capital: 26787205000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Investing Cash Flow: 161391000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Investment Properties: 5265591000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Investmentin Financial Assets: 350468000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Investments And Advances: 3939697000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Investments In Other Ventures Under Equity Method: 3589229000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Issuance Of Debt: 1100000000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Loans Receivable: 1939489000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Long Term Debt: 4208125000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Long Term Debt And Capital Lease Obligation: 4208125000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Long Term Debt Issuance: 1100000000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Long Term Debt Payments: -512729000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Long Term Equity Investment: 3589229000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Minority Interest: 152802000.00
LEN.B income_statement (quarterly, 2025-05-31) — Minority Interests: -4371000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Net Business Purchase And Sale: -89851000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Net Common Stock Issuance: -521419000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Net Debt: 2800431000.00
LEN.B income_statement (quarterly, 2025-05-31) — Net Income: 477449000.00
LEN.B income_statement (quarterly, 2025-05-31) — Net Income Common Stockholders: 471172000.00
LEN.B income_statement (quarterly, 2025-05-31) — Net Income Continuous Operations: 481820000.00
LEN.B income_statement (quarterly, 2025-05-31) — Net Income From Continuing And Discontinued Operation: 477449000.00
LEN.B income_statement (quarterly, 2025-05-31) — Net Income From Continuing Operation Net Minority Interest: 477449000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Net Income From Continuing Operations: 481820000.00
LEN.B income_statement (quarterly, 2025-05-31) — Net Income Including Noncontrolling Interests: 481820000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Net Investment Purchase And Sale: 612000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Net Issuance Payments Of Debt: 606284000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Net Long Term Debt Issuance: 587271000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Net Other Financing Charges: -126645000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Net Other Investing Changes: 126098000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Net PPE: 13965000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Net PPE Purchase And Sale: -15216000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Net Short Term Debt Issuance: 19013000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Net Tangible Assets: 18947022000.00
LEN.B income_statement (quarterly, 2025-05-31) — Normalized EBITDA: 711842000.00
LEN.B income_statement (quarterly, 2025-05-31) — Normalized Income: 499499560.00
LEN.B cash_flow (quarterly, 2025-05-31) — Operating Cash Flow: -1095022000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Operating Gains Losses: 3130000.00
LEN.B income_statement (quarterly, 2025-05-31) — Operating Income: 648577000.00
LEN.B income_statement (quarterly, 2025-05-31) — Operating Revenue: 8377502000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Ordinary Shares Number: 259006833.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Other Equity Adjustments: 6019000.00
LEN.B income_statement (quarterly, 2025-05-31) — Other Gand A: 155853000.00
LEN.B income_statement (quarterly, 2025-05-31) — Other Income Expense: -6696000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Other Inventories: 3141339000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Other Non Cash Items: -38725000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Other Non Current Assets: 2078119000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Other Non Current Liabilities: 4902493000.00
LEN.B income_statement (quarterly, 2025-05-31) — Other Non Operating Income Expenses: 10628000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Other Short Term Investments: 39069000.00
LEN.B income_statement (quarterly, 2025-05-31) — Otherunder Preferred Stock Dividend: 6277000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Payables: 2126002000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Payables And Accrued Expenses: 2126002000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Preferred Stock: 0.00
LEN.B income_statement (quarterly, 2025-05-31) — Pretax Income: 641881000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Purchase Of Business: -89851000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Purchase Of Investment: 0.00
LEN.B cash_flow (quarterly, 2025-05-31) — Purchase Of PPE: -15216000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Receivables: 3410232000.00
LEN.B income_statement (quarterly, 2025-05-31) — Reconciled Cost Of Revenue: 7573072000.00
LEN.B income_statement (quarterly, 2025-05-31) — Reconciled Depreciation: 33825000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Repayment Of Debt: -493716000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Repurchase Of Capital Stock: -521419000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Restricted Cash: 71321000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Retained Earnings: 21645991000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Sale Of Business: 0.00
LEN.B cash_flow (quarterly, 2025-05-31) — Sale Of Investment: 612000.00
LEN.B income_statement (quarterly, 2025-05-31) — Selling General And Administration: 155853000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Share Issued: 297957073.00
LEN.B cash_flow (quarterly, 2025-05-31) — Short Term Debt Payments: 19013000.00
LEN.B cash_flow (quarterly, 2025-05-31) — Stock Based Compensation: 28773000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Stockholders Equity: 22579080000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Tangible Book Value: 18947022000.00
LEN.B income_statement (quarterly, 2025-05-31) — Tax Effect Of Unusual Items: -7389440.00
LEN.B income_statement (quarterly, 2025-05-31) — Tax Provision: 160061000.00
LEN.B income_statement (quarterly, 2025-05-31) — Tax Rate For Calcs: 0.25
LEN.B balance_sheet (quarterly, 2025-05-31) — Total Assets: 34374546000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Total Capitalization: 26787205000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Total Debt: 4208125000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Total Equity Gross Minority Interest: 22731882000.00
LEN.B income_statement (quarterly, 2025-05-31) — Total Expenses: 7728925000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Total Liabilities Net Minority Interest: 11642664000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Total Non Current Assets: 14929430000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Total Non Current Liabilities Net Minority Interest: 9516662000.00
LEN.B income_statement (quarterly, 2025-05-31) — Total Unusual Items: -29440000.00
LEN.B income_statement (quarterly, 2025-05-31) — Total Unusual Items Excluding Goodwill: -29440000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Tradeand Other Payables Non Current: 406044000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Treasury Shares Number: 38950240.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Treasury Stock: 4945458000.00
LEN.B balance_sheet (quarterly, 2025-05-31) — Working Capital: 17319114000.00
LEN.B income_statement (quarterly, 2025-08-31) — +Operating Expense: 171397000.00
LEN.B income_statement (quarterly, 2025-08-31) — +Total Revenue: 8810278000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Accounts Payable: 1521244000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Accounts Receivable: 1550283000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Additional Paid In Capital: 5884528000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Available For Sale Securities: 285589000.00
LEN.B income_statement (quarterly, 2025-08-31) — Basic Average Shares: 255601000.00
LEN.B income_statement (quarterly, 2025-08-31) — Basic EPS: 2.29
LEN.B cash_flow (quarterly, 2025-08-31) — Beginning Cash Position: 1479015000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Capital Expenditure: -32165000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Capital Stock: 29813000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Cash And Cash Equivalents: 1662213000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Cash Cash Equivalents And Short Term Investments: 1701282000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Cash Dividends Paid: -129122000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Financing Activities: 443840000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Investing Activities: -7247000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Operating Activities: -158611000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Change In Account Payable: -378022000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Change In Inventory: 309653000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Change In Other Current Assets: -438598000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Change In Payable: -378022000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Change In Payables And Accrued Expense: -378022000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Change In Prepaid Assets: -466674000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Change In Receivables: 160509000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Change In Working Capital: -813132000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Changes In Cash: 277982000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Common Stock: 29813000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Common Stock Dividend Paid: -129122000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Common Stock Equity: 22570320000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Common Stock Payments: -512418000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Construction In Progress: 15425000.00
LEN.B income_statement (quarterly, 2025-08-31) — Cost Of Revenue: 7917683000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Current Assets: 19128133000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Current Liabilities: 1521244000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Deferred Income Tax: 38951000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Deferred Tax: 38951000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Depreciation Amortization Depletion: 34169000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Depreciation And Amortization: 34169000.00
LEN.B income_statement (quarterly, 2025-08-31) — Diluted Average Shares: 255601000.00
LEN.B income_statement (quarterly, 2025-08-31) — Diluted EPS: 2.29
LEN.B income_statement (quarterly, 2025-08-31) — Diluted NI Availto Com Stockholders: 585719000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Dividend Received Cfo: 8196000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Dividends Received Cfi: 60390000.00
LEN.B income_statement (quarterly, 2025-08-31) — EBIT: 721198000.00
LEN.B income_statement (quarterly, 2025-08-31) — EBITDA: 755367000.00
LEN.B income_statement (quarterly, 2025-08-31) — Earnings From Equity Interest: 10822000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Earnings Losses From Equity Investments: -10821000.00
LEN.B cash_flow (quarterly, 2025-08-31) — End Cash Position: 1756997000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Financing Cash Flow: 443840000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Finished Goods: 11119086000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Free Cash Flow: -190776000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Gain Loss On Investment Securities: -100020000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Gain Loss On Sale Of Business: -645000.00
LEN.B income_statement (quarterly, 2025-08-31) — Gain On Sale Of Security: 99223000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Gains Losses Not Affecting Retained Earnings: 6019000.00
LEN.B income_statement (quarterly, 2025-08-31) — General And Administrative Expense: 171397000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Goodwill: 3632058000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Goodwill And Other Intangible Assets: 3632058000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Gross PPE: 15425000.00
LEN.B income_statement (quarterly, 2025-08-31) — Gross Profit: 892595000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Held To Maturity Securities: 133558000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Inventory: 13700156000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Invested Capital: 27957931000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Investing Cash Flow: -7247000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Investment Properties: 6012493000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Investmentin Financial Assets: 419147000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Investments And Advances: 3961899000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Investments In Other Ventures Under Equity Method: 3542752000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Issuance Of Debt: 740000000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Loans Receivable: 2081628000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Long Term Debt: 5387611000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Long Term Debt And Capital Lease Obligation: 5387611000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Long Term Debt Issuance: -400000000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Long Term Debt Payments: -8330000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Long Term Equity Investment: 3542752000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Minority Interest: 181235000.00
LEN.B income_statement (quarterly, 2025-08-31) — Minority Interests: -8844000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Net Business Purchase And Sale: -57516000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Net Common Stock Issuance: -512418000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Net Debt: 3725398000.00
LEN.B income_statement (quarterly, 2025-08-31) — Net Income: 590967000.00
LEN.B income_statement (quarterly, 2025-08-31) — Net Income Common Stockholders: 585719000.00
LEN.B income_statement (quarterly, 2025-08-31) — Net Income Continuous Operations: 599811000.00
LEN.B income_statement (quarterly, 2025-08-31) — Net Income From Continuing And Discontinued Operation: 590967000.00
LEN.B income_statement (quarterly, 2025-08-31) — Net Income From Continuing Operation Net Minority Interest: 590967000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Net Income From Continuing Operations: 599811000.00
LEN.B income_statement (quarterly, 2025-08-31) — Net Income Including Noncontrolling Interests: 599811000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Net Investment Purchase And Sale: 130492000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Net Issuance Payments Of Debt: 1179377000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Net Long Term Debt Issuance: -408330000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Net Other Financing Charges: -93997000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Net Other Investing Changes: -163251000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Net PPE: 15425000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Net PPE Purchase And Sale: 22638000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Net Short Term Debt Issuance: 1587707000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Net Tangible Assets: 18938262000.00
LEN.B income_statement (quarterly, 2025-08-31) — Normalized EBITDA: 656144000.00
LEN.B income_statement (quarterly, 2025-08-31) — Normalized Income: 515954412.00
LEN.B cash_flow (quarterly, 2025-08-31) — Operating Cash Flow: -158611000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Operating Gains Losses: -110975000.00
LEN.B income_statement (quarterly, 2025-08-31) — Operating Income: 721198000.00
LEN.B income_statement (quarterly, 2025-08-31) — Operating Revenue: 8810278000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Ordinary Shares Number: 255020543.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Other Equity Adjustments: 6019000.00
LEN.B income_statement (quarterly, 2025-08-31) — Other Gand A: 171397000.00
LEN.B income_statement (quarterly, 2025-08-31) — Other Income Expense: 69505000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Other Inventories: 2581070000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Other Non Cash Items: -2241000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Other Non Current Assets: 2128393000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Other Non Current Liabilities: 4797186000.00
LEN.B income_statement (quarterly, 2025-08-31) — Other Non Operating Income Expenses: -40540000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Other Short Term Investments: 39069000.00
LEN.B income_statement (quarterly, 2025-08-31) — Otherunder Preferred Stock Dividend: 5248000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Payables: 1521244000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Payables And Accrued Expenses: 1521244000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Preferred Stock: 0.00
LEN.B income_statement (quarterly, 2025-08-31) — Pretax Income: 790703000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Purchase Of Business: -57516000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Purchase Of Investment: 0.00
LEN.B cash_flow (quarterly, 2025-08-31) — Purchase Of PPE: -32165000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Receivables: 3631911000.00
LEN.B income_statement (quarterly, 2025-08-31) — Reconciled Cost Of Revenue: 7917683000.00
LEN.B income_statement (quarterly, 2025-08-31) — Reconciled Depreciation: 34169000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Repayment Of Debt: 439377000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Repurchase Of Capital Stock: -512418000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Restricted Cash: 94784000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Retained Earnings: 22107836000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Sale Of Business: 0.00
LEN.B cash_flow (quarterly, 2025-08-31) — Sale Of Investment: 130492000.00
LEN.B income_statement (quarterly, 2025-08-31) — Selling General And Administration: 171397000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Share Issued: 298131792.00
LEN.B cash_flow (quarterly, 2025-08-31) — Short Term Debt Payments: 447707000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Stock Based Compensation: 25505000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Stockholders Equity: 22570320000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Tangible Book Value: 18938262000.00
LEN.B income_statement (quarterly, 2025-08-31) — Tax Effect Of Unusual Items: 24210412.00
LEN.B income_statement (quarterly, 2025-08-31) — Tax Provision: 190892000.00
LEN.B income_statement (quarterly, 2025-08-31) — Tax Rate For Calcs: 0.24
LEN.B balance_sheet (quarterly, 2025-08-31) — Total Assets: 34878401000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Total Capitalization: 27957931000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Total Debt: 5387611000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Total Equity Gross Minority Interest: 22751555000.00
LEN.B income_statement (quarterly, 2025-08-31) — Total Expenses: 8089080000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Total Liabilities Net Minority Interest: 12126846000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Total Non Current Assets: 15750268000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Total Non Current Liabilities Net Minority Interest: 10605602000.00
LEN.B income_statement (quarterly, 2025-08-31) — Total Unusual Items: 99223000.00
LEN.B income_statement (quarterly, 2025-08-31) — Total Unusual Items Excluding Goodwill: 99223000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Tradeand Other Payables Non Current: 420805000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Treasury Shares Number: 43111249.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Treasury Stock: 5457876000.00
LEN.B cash_flow (quarterly, 2025-08-31) — Unrealized Gain Loss On Investment Securities: 61105000.00
LEN.B balance_sheet (quarterly, 2025-08-31) — Working Capital: 17606889000.00
LEN.B income_statement (annual, 2025-11-30) — +Operating Expense: 636718000.00
LEN.B income_statement (quarterly, 2025-11-30) — +Operating Expense: 162090000.00
LEN.B income_statement (annual, 2025-11-30) — +Total Revenue: 34186934000.00
LEN.B income_statement (quarterly, 2025-11-30) — +Total Revenue: 9367609000.00
LEN.B balance_sheet (annual, 2025-11-30) — Accounts Payable: 1812484000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Accounts Payable: 1812484000.00
LEN.B balance_sheet (annual, 2025-11-30) — Accounts Receivable: 1310019000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Accounts Receivable: 1310019000.00
LEN.B balance_sheet (annual, 2025-11-30) — Accumulated Depreciation: -315175000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Accumulated Depreciation: -315175000.00
LEN.B balance_sheet (annual, 2025-11-30) — Additional Paid In Capital: 5909726000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Additional Paid In Capital: 5909726000.00
LEN.B balance_sheet (annual, 2025-11-30) — Available For Sale Securities: 346820000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Available For Sale Securities: 346820000.00
LEN.B income_statement (annual, 2025-11-30) — Basic Average Shares: 257746000.00
LEN.B income_statement (quarterly, 2025-11-30) — Basic Average Shares: 252363000.00
LEN.B income_statement (annual, 2025-11-30) — Basic EPS: 7.98
LEN.B income_statement (quarterly, 2025-11-30) — Basic EPS: 1.93
LEN.B cash_flow (annual, 2025-11-30) — Beginning Cash Position: 4990210000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Beginning Cash Position: 1756997000.00
LEN.B cash_flow (annual, 2025-11-30) — Capital Expenditure: -188629000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Capital Expenditure: -85205000.00
LEN.B balance_sheet (annual, 2025-11-30) — Capital Stock: 29818000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Capital Stock: 29818000.00
LEN.B balance_sheet (annual, 2025-11-30) — Cash And Cash Equivalents: 3756305000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 3756305000.00
LEN.B balance_sheet (annual, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 3795365000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 3795365000.00
LEN.B cash_flow (annual, 2025-11-30) — Cash Dividends Paid: -520959000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Cash Dividends Paid: -126602000.00
LEN.B cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Financing Activities: -1597856000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Financing Activities: 268316000.00
LEN.B cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Investing Activities: 221568000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Investing Activities: 45934000.00
LEN.B cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Operating Activities: 216812000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Operating Activities: 1759487000.00
LEN.B cash_flow (annual, 2025-11-30) — Change In Account Payable: -690751000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Change In Account Payable: 287297000.00
LEN.B cash_flow (annual, 2025-11-30) — Change In Inventory: -150921000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Change In Inventory: 1164012000.00
LEN.B cash_flow (annual, 2025-11-30) — Change In Other Current Assets: -62338000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Change In Other Current Assets: 147554000.00
LEN.B cash_flow (annual, 2025-11-30) — Change In Payable: -690751000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Change In Payable: 287297000.00
LEN.B cash_flow (annual, 2025-11-30) — Change In Payables And Accrued Expense: -690751000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Change In Payables And Accrued Expense: 287297000.00
LEN.B cash_flow (annual, 2025-11-30) — Change In Prepaid Assets: -1549664000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Change In Prepaid Assets: -301274000.00
LEN.B cash_flow (annual, 2025-11-30) — Change In Receivables: 66764000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Change In Receivables: -163344000.00
LEN.B cash_flow (annual, 2025-11-30) — Change In Working Capital: -2386910000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Change In Working Capital: 1134245000.00
LEN.B cash_flow (annual, 2025-11-30) — Changes In Cash: -1159476000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Changes In Cash: 2073737000.00
LEN.B balance_sheet (annual, 2025-11-30) — Common Stock: 29818000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Common Stock: 29818000.00
LEN.B cash_flow (annual, 2025-11-30) — Common Stock Dividend Paid: -520959000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Common Stock Dividend Paid: -126602000.00
LEN.B balance_sheet (annual, 2025-11-30) — Common Stock Equity: 21959417000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 21959417000.00
LEN.B cash_flow (annual, 2025-11-30) — Common Stock Payments: -1808369000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Common Stock Payments: -57000.00
LEN.B balance_sheet (annual, 2025-11-30) — Construction In Progress: 6398729000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Construction In Progress: 6398729000.00
LEN.B income_statement (annual, 2025-11-30) — Cost Of Revenue: 30799809000.00
LEN.B income_statement (quarterly, 2025-11-30) — Cost Of Revenue: 8538560000.00
LEN.B balance_sheet (annual, 2025-11-30) — Current Assets: 19394535000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Current Assets: 19394535000.00
LEN.B balance_sheet (annual, 2025-11-30) — Current Liabilities: 1812484000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Current Liabilities: 1812484000.00
LEN.B cash_flow (annual, 2025-11-30) — Deferred Income Tax: 77295000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Deferred Income Tax: -37000.00
LEN.B cash_flow (annual, 2025-11-30) — Deferred Tax: 77295000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Deferred Tax: -37000.00
LEN.B cash_flow (annual, 2025-11-30) — Depreciation Amortization Depletion: 134310000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Depreciation Amortization Depletion: 34984000.00
LEN.B cash_flow (annual, 2025-11-30) — Depreciation And Amortization: 134310000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Depreciation And Amortization: 34984000.00
LEN.B income_statement (annual, 2025-11-30) — Diluted Average Shares: 257746000.00
LEN.B income_statement (quarterly, 2025-11-30) — Diluted Average Shares: 252363000.00
LEN.B income_statement (annual, 2025-11-30) — Diluted EPS: 7.98
LEN.B income_statement (quarterly, 2025-11-30) — Diluted EPS: 1.93
LEN.B income_statement (annual, 2025-11-30) — Diluted NI Availto Com Stockholders: 2058083000.00
LEN.B income_statement (quarterly, 2025-11-30) — Diluted NI Availto Com Stockholders: 486497000.00
LEN.B cash_flow (annual, 2025-11-30) — Dividend Received Cfo: 36578000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Dividend Received Cfo: 8312000.00
LEN.B cash_flow (annual, 2025-11-30) — Dividends Received Cfi: 281536000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Dividends Received Cfi: 45943000.00
LEN.B income_statement (annual, 2025-11-30) — EBIT: 2750407000.00
LEN.B income_statement (quarterly, 2025-11-30) — EBIT: 666959000.00
LEN.B income_statement (annual, 2025-11-30) — EBITDA: 2884717000.00
LEN.B income_statement (quarterly, 2025-11-30) — EBITDA: 701943000.00
LEN.B income_statement (annual, 2025-11-30) — Earnings From Equity Interest: 78225000.00
LEN.B income_statement (quarterly, 2025-11-30) — Earnings From Equity Interest: 22053000.00
LEN.B cash_flow (annual, 2025-11-30) — Earnings Losses From Equity Investments: -78225000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Earnings Losses From Equity Investments: -22053000.00
LEN.B cash_flow (annual, 2025-11-30) — End Cash Position: 3830734000.00
LEN.B cash_flow (quarterly, 2025-11-30) — End Cash Position: 3830734000.00
LEN.B cash_flow (annual, 2025-11-30) — Financing Cash Flow: -1597856000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Financing Cash Flow: 268316000.00
LEN.B balance_sheet (annual, 2025-11-30) — Finished Goods: 9921232000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Finished Goods: 9921232000.00
LEN.B cash_flow (annual, 2025-11-30) — Free Cash Flow: 28183000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Free Cash Flow: 1674282000.00
LEN.B cash_flow (annual, 2025-11-30) — Gain Loss On Investment Securities: 183702000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Gain Loss On Investment Securities: 193995000.00
LEN.B cash_flow (annual, 2025-11-30) — Gain Loss On Sale Of Business: 156076000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Gain Loss On Sale Of Business: 191754000.00
LEN.B cash_flow (annual, 2025-11-30) — Gain Loss On Sale Of PPE: -77737000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Gain Loss On Sale Of PPE: -43651000.00
LEN.B income_statement (annual, 2025-11-30) — Gain On Sale Of Security: 130166000.00
LEN.B income_statement (quarterly, 2025-11-30) — Gain On Sale Of Security: 122886000.00
LEN.B balance_sheet (annual, 2025-11-30) — Gains Losses Not Affecting Retained Earnings: 6011000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Gains Losses Not Affecting Retained Earnings: 6011000.00
LEN.B income_statement (annual, 2025-11-30) — General And Administrative Expense: 636718000.00
LEN.B income_statement (quarterly, 2025-11-30) — General And Administrative Expense: 162090000.00
LEN.B balance_sheet (annual, 2025-11-30) — Goodwill: 3632058000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Goodwill: 3632058000.00
LEN.B balance_sheet (annual, 2025-11-30) — Goodwill And Other Intangible Assets: 3632058000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Goodwill And Other Intangible Assets: 3632058000.00
LEN.B balance_sheet (annual, 2025-11-30) — Gross PPE: 7356742000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Gross PPE: 7356742000.00
LEN.B income_statement (annual, 2025-11-30) — Gross Profit: 3387125000.00
LEN.B income_statement (quarterly, 2025-11-30) — Gross Profit: 829049000.00
LEN.B balance_sheet (annual, 2025-11-30) — Held To Maturity Securities: 132868000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Held To Maturity Securities: 132868000.00
LEN.B cash_flow (annual, 2025-11-30) — Income Tax Paid Supplemental Data: 988544000.00
LEN.B cash_flow (annual, 2025-11-30) — Interest Paid Supplemental Data: 50137000.00
LEN.B balance_sheet (annual, 2025-11-30) — Inventory: 11841255000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Inventory: 11841255000.00
LEN.B balance_sheet (annual, 2025-11-30) — Invested Capital: 27834412000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Invested Capital: 27834412000.00
LEN.B cash_flow (annual, 2025-11-30) — Investing Cash Flow: 221568000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Investing Cash Flow: 45934000.00
LEN.B balance_sheet (annual, 2025-11-30) — Investmentin Financial Assets: 479688000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Investmentin Financial Assets: 479688000.00
LEN.B balance_sheet (annual, 2025-11-30) — Investments And Advances: 2902124000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Investments And Advances: 2902124000.00
LEN.B balance_sheet (annual, 2025-11-30) — Investments In Other Ventures Under Equity Method: 2422436000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Investments In Other Ventures Under Equity Method: 2422436000.00
LEN.B cash_flow (annual, 2025-11-30) — Issuance Of Debt: 2410000000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Issuance Of Debt: 570000000.00
LEN.B balance_sheet (annual, 2025-11-30) — Leases: 75921000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Leases: 75921000.00
LEN.B balance_sheet (annual, 2025-11-30) — Loans Receivable: 2212624000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Loans Receivable: 2212624000.00
LEN.B balance_sheet (annual, 2025-11-30) — Long Term Debt: 5874995000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Long Term Debt: 5874995000.00
LEN.B balance_sheet (annual, 2025-11-30) — Long Term Debt And Capital Lease Obligation: 5874995000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Long Term Debt And Capital Lease Obligation: 5874995000.00
LEN.B cash_flow (annual, 2025-11-30) — Long Term Debt Issuance: 2410000000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Long Term Debt Issuance: 1710000000.00
LEN.B cash_flow (annual, 2025-11-30) — Long Term Debt Payments: -557860000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Long Term Debt Payments: -9201000.00
LEN.B balance_sheet (annual, 2025-11-30) — Long Term Equity Investment: 2422436000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Long Term Equity Investment: 2422436000.00
LEN.B balance_sheet (annual, 2025-11-30) — Machinery Furniture Equipment: 390387000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Machinery Furniture Equipment: 390387000.00
LEN.B balance_sheet (annual, 2025-11-30) — Minority Interest: 181192000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Minority Interest: 181192000.00
LEN.B income_statement (annual, 2025-11-30) — Minority Interests: -30121000.00
LEN.B income_statement (quarterly, 2025-11-30) — Minority Interests: -7719000.00
LEN.B cash_flow (annual, 2025-11-30) — Net Business Purchase And Sale: -249533000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Net Business Purchase And Sale: -25038000.00
LEN.B cash_flow (annual, 2025-11-30) — Net Common Stock Issuance: -1808369000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Net Common Stock Issuance: -57000.00
LEN.B balance_sheet (annual, 2025-11-30) — Net Debt: 2118690000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Net Debt: 2118690000.00
LEN.B income_statement (annual, 2025-11-30) — Net Income: 2078179000.00
LEN.B income_statement (quarterly, 2025-11-30) — Net Income: 490237000.00
LEN.B income_statement (annual, 2025-11-30) — Net Income Common Stockholders: 2058083000.00
LEN.B income_statement (quarterly, 2025-11-30) — Net Income Common Stockholders: 486497000.00
LEN.B income_statement (annual, 2025-11-30) — Net Income Continuous Operations: 2108300000.00
LEN.B income_statement (quarterly, 2025-11-30) — Net Income Continuous Operations: 497956000.00
LEN.B income_statement (annual, 2025-11-30) — Net Income From Continuing And Discontinued Operation: 2078179000.00
LEN.B income_statement (quarterly, 2025-11-30) — Net Income From Continuing And Discontinued Operation: 490237000.00
LEN.B income_statement (annual, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: 2078179000.00
LEN.B income_statement (quarterly, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: 490237000.00
LEN.B cash_flow (annual, 2025-11-30) — Net Income From Continuing Operations: 2108300000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Net Income From Continuing Operations: 497956000.00
LEN.B income_statement (annual, 2025-11-30) — Net Income Including Noncontrolling Interests: 2108300000.00
LEN.B income_statement (quarterly, 2025-11-30) — Net Income Including Noncontrolling Interests: 497956000.00
LEN.B cash_flow (annual, 2025-11-30) — Net Investment Purchase And Sale: 101129000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Net Investment Purchase And Sale: -100456000.00
LEN.B cash_flow (annual, 2025-11-30) — Net Issuance Payments Of Debt: 1711492000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Net Issuance Payments Of Debt: 487262000.00
LEN.B cash_flow (annual, 2025-11-30) — Net Long Term Debt Issuance: 1852140000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Net Long Term Debt Issuance: 1700799000.00
LEN.B cash_flow (annual, 2025-11-30) — Net Other Financing Charges: -980020000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Net Other Financing Charges: -92287000.00
LEN.B cash_flow (annual, 2025-11-30) — Net Other Investing Changes: 126241000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Net Other Investing Changes: 114669000.00
LEN.B balance_sheet (annual, 2025-11-30) — Net PPE: 7041567000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Net PPE: 7041567000.00
LEN.B cash_flow (annual, 2025-11-30) — Net PPE Purchase And Sale: -37805000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Net PPE Purchase And Sale: 10816000.00
LEN.B cash_flow (annual, 2025-11-30) — Net Short Term Debt Issuance: -140648000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Net Short Term Debt Issuance: -1213537000.00
LEN.B balance_sheet (annual, 2025-11-30) — Net Tangible Assets: 18327359000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 18327359000.00
LEN.B income_statement (annual, 2025-11-30) — Normalized EBITDA: 2754551000.00
LEN.B income_statement (quarterly, 2025-11-30) — Normalized EBITDA: 579057000.00
LEN.B income_statement (annual, 2025-11-30) — Normalized Income: 1981010081.00
LEN.B income_statement (quarterly, 2025-11-30) — Normalized Income: 400649667.74
LEN.B balance_sheet (annual, 2025-11-30) — Notes Receivable: 161672000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Notes Receivable: 161672000.00
LEN.B cash_flow (annual, 2025-11-30) — Operating Cash Flow: 216812000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Operating Cash Flow: 1759487000.00
LEN.B cash_flow (annual, 2025-11-30) — Operating Gains Losses: 183816000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Operating Gains Losses: 320045000.00
LEN.B income_statement (annual, 2025-11-30) — Operating Income: 2750407000.00
LEN.B income_statement (quarterly, 2025-11-30) — Operating Income: 666959000.00
LEN.B income_statement (annual, 2025-11-30) — Operating Revenue: 34186934000.00
LEN.B income_statement (quarterly, 2025-11-30) — Operating Revenue: 9367609000.00
LEN.B balance_sheet (annual, 2025-11-30) — Ordinary Shares Number: 246991918.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 246991918.00
LEN.B balance_sheet (annual, 2025-11-30) — Other Equity Adjustments: 6011000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Other Equity Adjustments: 6011000.00
LEN.B income_statement (annual, 2025-11-30) — Other Gand A: 636718000.00
LEN.B income_statement (quarterly, 2025-11-30) — Other Gand A: 162090000.00
LEN.B income_statement (annual, 2025-11-30) — Other Income Expense: 63456000.00
LEN.B income_statement (quarterly, 2025-11-30) — Other Income Expense: 16082000.00
LEN.B balance_sheet (annual, 2025-11-30) — Other Inventories: 1920023000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Other Inventories: 1920023000.00
LEN.B cash_flow (annual, 2025-11-30) — Other Non Cash Items: 88000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Other Non Cash Items: 121000.00
LEN.B balance_sheet (annual, 2025-11-30) — Other Non Current Assets: 1460153000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Other Non Current Assets: 1460153000.00
LEN.B balance_sheet (annual, 2025-11-30) — Other Non Current Liabilities: 4168252000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Other Non Current Liabilities: 4168252000.00
LEN.B income_statement (annual, 2025-11-30) — Other Non Operating Income Expenses: -144935000.00
LEN.B income_statement (quarterly, 2025-11-30) — Other Non Operating Income Expenses: -128857000.00
LEN.B balance_sheet (annual, 2025-11-30) — Other Properties: 491705000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Other Properties: 491705000.00
LEN.B balance_sheet (annual, 2025-11-30) — Other Short Term Investments: 39060000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Other Short Term Investments: 39060000.00
LEN.B income_statement (annual, 2025-11-30) — Otherunder Preferred Stock Dividend: 20096000.00
LEN.B income_statement (quarterly, 2025-11-30) — Otherunder Preferred Stock Dividend: 3740000.00
LEN.B balance_sheet (annual, 2025-11-30) — Payables: 1812484000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Payables: 1812484000.00
LEN.B balance_sheet (annual, 2025-11-30) — Payables And Accrued Expenses: 1812484000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Payables And Accrued Expenses: 1812484000.00
LEN.B balance_sheet (annual, 2025-11-30) — Preferred Stock: 0.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Preferred Stock: 0.00
LEN.B income_statement (annual, 2025-11-30) — Pretax Income: 2813863000.00
LEN.B income_statement (quarterly, 2025-11-30) — Pretax Income: 683041000.00
LEN.B balance_sheet (annual, 2025-11-30) — Properties: 0.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Properties: 0.00
LEN.B cash_flow (annual, 2025-11-30) — Purchase Of Business: -508205000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Purchase Of Business: -50703000.00
LEN.B cash_flow (annual, 2025-11-30) — Purchase Of Investment: -3456000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Purchase Of Investment: 0.00
LEN.B cash_flow (annual, 2025-11-30) — Purchase Of PPE: -188629000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Purchase Of PPE: -85205000.00
LEN.B balance_sheet (annual, 2025-11-30) — Receivables: 3683486000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Receivables: 3683486000.00
LEN.B balance_sheet (annual, 2025-11-30) — Receivables Adjustments Allowances: -829000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Receivables Adjustments Allowances: -829000.00
LEN.B income_statement (annual, 2025-11-30) — Reconciled Cost Of Revenue: 30799809000.00
LEN.B income_statement (quarterly, 2025-11-30) — Reconciled Cost Of Revenue: 8538560000.00
LEN.B income_statement (annual, 2025-11-30) — Reconciled Depreciation: 134310000.00
LEN.B income_statement (quarterly, 2025-11-30) — Reconciled Depreciation: 34984000.00
LEN.B cash_flow (annual, 2025-11-30) — Repayment Of Debt: -557860000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Repayment Of Debt: 57910000.00
LEN.B cash_flow (annual, 2025-11-30) — Repurchase Of Capital Stock: -1808369000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Repurchase Of Capital Stock: -57000.00
LEN.B balance_sheet (annual, 2025-11-30) — Restricted Cash: 74429000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Restricted Cash: 74429000.00
LEN.B balance_sheet (annual, 2025-11-30) — Retained Earnings: 22471471000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Retained Earnings: 22471471000.00
LEN.B cash_flow (annual, 2025-11-30) — Sale Of Business: 258672000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Sale Of Business: 25665000.00
LEN.B cash_flow (annual, 2025-11-30) — Sale Of Investment: 104585000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Sale Of Investment: -100456000.00
LEN.B cash_flow (annual, 2025-11-30) — Sale Of PPE: 150824000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Sale Of PPE: 96021000.00
LEN.B income_statement (annual, 2025-11-30) — Selling General And Administration: 636718000.00
LEN.B income_statement (quarterly, 2025-11-30) — Selling General And Administration: 162090000.00
LEN.B balance_sheet (annual, 2025-11-30) — Share Issued: 298180468.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Share Issued: 298180468.00
LEN.B cash_flow (annual, 2025-11-30) — Stock Based Compensation: 163494000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Stock Based Compensation: 25131000.00
LEN.B balance_sheet (annual, 2025-11-30) — Stockholders Equity: 21959417000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 21959417000.00
LEN.B balance_sheet (annual, 2025-11-30) — Tangible Book Value: 18327359000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 18327359000.00
LEN.B income_statement (annual, 2025-11-30) — Tax Effect Of Unusual Items: 32997081.00
LEN.B income_statement (quarterly, 2025-11-30) — Tax Effect Of Unusual Items: 33298667.74
LEN.B income_statement (annual, 2025-11-30) — Tax Provision: 705563000.00
LEN.B income_statement (quarterly, 2025-11-30) — Tax Provision: 185085000.00
LEN.B income_statement (annual, 2025-11-30) — Tax Rate For Calcs: 0.25
LEN.B income_statement (quarterly, 2025-11-30) — Tax Rate For Calcs: 0.27
LEN.B balance_sheet (annual, 2025-11-30) — Total Assets: 34430437000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Total Assets: 34430437000.00
LEN.B balance_sheet (annual, 2025-11-30) — Total Capitalization: 27834412000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Total Capitalization: 27834412000.00
LEN.B balance_sheet (annual, 2025-11-30) — Total Debt: 5874995000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Total Debt: 5874995000.00
LEN.B balance_sheet (annual, 2025-11-30) — Total Equity Gross Minority Interest: 22140609000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 22140609000.00
LEN.B income_statement (annual, 2025-11-30) — Total Expenses: 31436527000.00
LEN.B income_statement (quarterly, 2025-11-30) — Total Expenses: 8700650000.00
LEN.B balance_sheet (annual, 2025-11-30) — Total Liabilities Net Minority Interest: 12289828000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 12289828000.00
LEN.B balance_sheet (annual, 2025-11-30) — Total Non Current Assets: 15035902000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Total Non Current Assets: 15035902000.00
LEN.B balance_sheet (annual, 2025-11-30) — Total Non Current Liabilities Net Minority Interest: 10477344000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Total Non Current Liabilities Net Minority Interest: 10477344000.00
LEN.B income_statement (annual, 2025-11-30) — Total Unusual Items: 130166000.00
LEN.B income_statement (quarterly, 2025-11-30) — Total Unusual Items: 122886000.00
LEN.B income_statement (annual, 2025-11-30) — Total Unusual Items Excluding Goodwill: 130166000.00
LEN.B income_statement (quarterly, 2025-11-30) — Total Unusual Items Excluding Goodwill: 122886000.00
LEN.B balance_sheet (annual, 2025-11-30) — Tradeand Other Payables Non Current: 434097000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Tradeand Other Payables Non Current: 434097000.00
LEN.B balance_sheet (annual, 2025-11-30) — Treasury Shares Number: 51188550.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Treasury Shares Number: 51188550.00
LEN.B balance_sheet (annual, 2025-11-30) — Treasury Stock: 6457609000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Treasury Stock: 6457609000.00
LEN.B cash_flow (annual, 2025-11-30) — Unrealized Gain Loss On Investment Securities: -100159000.00
LEN.B cash_flow (quarterly, 2025-11-30) — Unrealized Gain Loss On Investment Securities: -261270000.00
LEN.B balance_sheet (annual, 2025-11-30) — Working Capital: 17582051000.00
LEN.B balance_sheet (quarterly, 2025-11-30) — Working Capital: 17582051000.00
LEN.B income_statement (quarterly, 2026-02-28) — +Operating Expense: 157638000.00
LEN.B income_statement (quarterly, 2026-02-28) — +Total Revenue: 6619476000.00
LEN.B balance_sheet (quarterly, 2026-02-28) — Accounts Payable: 1737575000.00
LEN.B balance_sheet (quarterly, 2026-02-28) — Accounts Receivable: 1306260000.00
LEN.B balance_sheet (quarterly, 2026-02-28) — Additional Paid In Capital: 5993733000.00
LEN.B balance_sheet (quarterly, 2026-02-28) — Available For Sale Securities: 222460000.00
LEN.B income_statement (quarterly, 2026-02-28) — Basic Average Shares: 244438000.00
LEN.B income_statement (quarterly, 2026-02-28) — Basic EPS: 0.93
LEN.B cash_flow (quarterly, 2026-02-28) — Beginning Cash Position: 3830734000.00
LEN.B cash_flow (quarterly, 2026-02-28) — Capital Expenditure: -29992000.00
LEN.B balance_sheet (quarterly, 2026-02-28) — Capital Stock: 29979000.00
LEN.B balance_sheet (quarterly, 2026-02-28) — Cash And Cash Equivalents: 2352642000.00
LEN.B balance_sheet (quarterly, 2026-02-28) — Cash Cash Equivalents And Short Term Investments: 2391297000.00